MRSA Keratitis and Conjunctivitis: What Does It Mean Practically?

Tarika Thareja,Regis P. Kowalski,Vishal Jhanji,Roheena Kamyar,Deepinder K. Dhaliwal
DOI: https://doi.org/10.1007/s40135-019-00206-z
2019-04-30
Current Ophthalmology Reports
Abstract:Purpose of ReviewThis paper aims to review the epidemiology and clinical spectrum of two of the most common ophthalmic manifestations of methicillin-resistant Staphylococcus aureus (MRSA) infection, conjunctivitis, and keratitis. Recent data on antimicrobial resistance patterns and its clinical implications will be reviewed, as well as strategies for ophthalmologists to adequately treat infections and curtail the progress of resistance.Recent FindingsThere have been reports that the prevalence of MRSA ocular infections has been increasing and is associated with an increase in resistance to fluoroquinolones based on systemic standards. Notably, with community-acquired MRSA (CA-MRSA) on the rise, colonization and infection with MRSA is no longer exclusive to those with traditional risk factors.SummaryKey strategies including culture-directed treatment with potent antimicrobials, effective antimicrobial dosing, empirical treatment based on local trends, and utilization of antiseptic strategies and antibiotic cycling should be utilized by clinicians to limit the spread of MRSA ophthalmic infections.
What problem does this paper attempt to address?